Prior Authorization Criteria for Michigan Medicaid To qualify for Wegovy coverage under Michigan Medicaid, a prescriber typically must document: BMI 30 kg/m, or BMI 27 kg/m with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea) Participation in or referral to a behavioral weight-management program Absence of contraindications listed in the FDA label, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (FDA prescribing information) Prescriber attestation that the patient has attempted lifestyle modification for at least 90 days PA approvals are typically granted for six months initially, with renewal requiring documented weight loss of at least 5% body weight
La semaglutida ayuda a perder peso al promover la quema de grasa y preservar la masa muscular, pero es importante mantenerse activo para mantener el tono muscular y garantizar que la prdida de peso provenga principalmente de grasa
United States Food and Drug Administration
Regular follow-ups ensure progress stays on track
Weight loss was also a goal
Understanding proper technique from the outset reduces anxiety and minimizes the risk of injection-related complications
/assets/images/provider/photos/2798511.png)
